Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Report Updates on tofersen Phase 3 VALOR study in SOD1-ALS
Go back to Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Report Updates on tofersen Phase 3 VALOR study in SOD1-ALS| (NASDAQ: IONS) | Delayed: 74.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.12 | 52 Week High | $62.68 | |||
| Open | $74.12 | 52 Week Low | $19.59 | |||
| Day High | $74.12 | P/E | N/A | |||
| Day Low | $74.12 | EPS | $0.00 | |||
| Volume | 429 | |||||

